TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MGNX

MacroGenics Inc

Healthcare · Biotechnology

4.10$ -0.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement MGNX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+113.4% -14.2% +79.6% -61.3% +3.2% +57.6% -22.6% +100.9% -62.4% +159.4% +0.8%
+16.6% +24.2% +20.6% +29.6% +2.3% -1.1% -98.6% +178.5% +11.3% +49.6% +251.1%
+113.4% -14.2% +79.6% -61.3% +3.2% +57.6% -25.3% +98.0% -66.1% +177.8% -21.8%
+40.0% +24.2% +20.6% +29.6% +2.3% -1.1% +11.1% -3.5% -19.5% +6.4% -21.0%
+42.9% +31.0% +9.5% +24.0% +13.7% -7.2% +47.4% -6.5% -11.5% +36.1% -44.9%
+41.4% +21.1% +21.2% +30.2% +3.4% -4.3% +20.5% -3.6% -18.3% +13.5% -27.4%
-61.3% +443.7% -22.0% +663.0%
-212.0% +3,503.5% -90.0% -171.2%
-2,944.2%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?